127 related articles for article (PubMed ID: 10195771)
1. Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide.
McInerney TL; Brennan FR; Jones TD; Dimmock NJ
Vaccine; 1999 Mar; 17(11-12):1359-68. PubMed ID: 10195771
[TBL] [Abstract][Full Text] [Related]
2. Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization.
Durrani Z; McInerney TL; McLain L; Jones T; Bellaby T; Brennan FR; Dimmock NJ
J Immunol Methods; 1998 Nov; 220(1-2):93-103. PubMed ID: 9839930
[TBL] [Abstract][Full Text] [Related]
3. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.
Chaitra MG; Nayak R; Shaila MS
Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus.
McLain L; Porta C; Lomonossoff GP; Durrani Z; Dimmock NJ
AIDS Res Hum Retroviruses; 1995 Mar; 11(3):327-34. PubMed ID: 7786579
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.
Leenaars PP; Hendriksen CF; Angulo AF; Koedam MA; Claassen E
Vet Immunol Immunopathol; 1994 Mar; 40(3):225-41. PubMed ID: 8160361
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
Gavin AL; Hoebe K; Duong B; Ota T; Martin C; Beutler B; Nemazee D
Science; 2006 Dec; 314(5807):1936-8. PubMed ID: 17185603
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
[TBL] [Abstract][Full Text] [Related]
8. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
9. Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.
Brennan FR; Bellaby T; Helliwell SM; Jones TD; Kamstrup S; Dalsgaard K; Flock JI; Hamilton WD
J Virol; 1999 Feb; 73(2):930-8. PubMed ID: 9882293
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus.
Brennan FR; Jones TD; Gilleland LB; Bellaby T; Xu F; North PC; Thompson A; Staczek J; Lin T; Johnson JE; Hamilton WDO; Gilleland HE
Microbiology (Reading); 1999 Jan; 145 ( Pt 1)():211-220. PubMed ID: 10206701
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.
Xiao W; Du L; Liang C; Guan J; Jiang S; Lustigman S; He Y; Zhou Y
Vaccine; 2008 Sep; 26(39):5022-9. PubMed ID: 18675867
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant.
Cargnelutti DE; Sanchez MA; Alvarez P; Boado L; Mattion N; Scodeller EA
New Microbiol; 2013 Apr; 36(2):145-51. PubMed ID: 23686120
[TBL] [Abstract][Full Text] [Related]
14. Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation.
Silveira F; Cibulski SP; Varela AP; Marqués JM; Chabalgoity A; de Costa F; Yendo AC; Gosmann G; Roehe PM; Fernández C; Ferreira F
Vaccine; 2011 Nov; 29(49):9177-82. PubMed ID: 22001878
[TBL] [Abstract][Full Text] [Related]
15. A chimaeric plant virus vaccine protects mice against a bacterial infection.
Brennan FR; Gilleland LB; Staczek J; Bendig MM; Hamilton WDO; Gilleland HE
Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2061-2067. PubMed ID: 10463172
[TBL] [Abstract][Full Text] [Related]
16. Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus.
Obeid OE; Stanley CM; Steward MW
Virus Res; 1996 Jun; 42(1-2):173-80. PubMed ID: 8806185
[TBL] [Abstract][Full Text] [Related]
17. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
[TBL] [Abstract][Full Text] [Related]
18. Low-dose intraperitoneal Freund's adjuvant: toxicity and immunogenicity in mice using an immunogen targeting amyloid-beta peptide.
Oscherwitz J; Hankenson FC; Yu F; Cease KB
Vaccine; 2006 Apr; 24(15):3018-25. PubMed ID: 16307832
[TBL] [Abstract][Full Text] [Related]
19. Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein.
Mody KT; Mahony D; Zhang J; Cavallaro AS; Zhang B; Popat A; Mahony TJ; Yu C; Mitter N
Biomaterials; 2014 Dec; 35(37):9972-9983. PubMed ID: 25239045
[TBL] [Abstract][Full Text] [Related]
20. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
